Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Egeler, R.M.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(21 - 40 of 92)

Pages

Mesenchymal Stromal Cell Therapy Is Associated With Increased Adenovirus-Associated but Not Cytomegalovirus-Associated Mortality in Children With Severe Acute Graft-Versus-Host Disease
Intact IFN-gamma R1 Expression and Function Distinguishes Langerhans Cell Histiocytosis From Mendelian Susceptibility to Mycobacterial Disease (vol 34, pg 84, 2014)
Somatic activating ARAF mutations in Langerhans cell histiocytosis
Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-gamma
Intact IFN-gamma R1 Expression and Function Distinguishes Langerhans Cell Histiocytosis From Mendelian Susceptibility to Mycobacterial Disease
Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-gamma
Gastrointestinal Acute Graft-versus-Host Disease in Children: Histology for Diagnosis, Mesenchymal Stromal Cells for Treatment, and Biomarkers for Prediction of Response
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease
ANALYSIS OF IFN-gamma R1 GENE EXPRESSION AND FUNCTION CAN DISTINGUISH LANGERHANS CELL HISTIOCYTOSIS PATIENTS FROM PATIENTS WITH MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE
Challenges and Opportunities for International Cooperative Studies in Pediatric Hematopoeitic Cell Transplantation: Priorities of the Westhafen Intercontinental Group
Biopsies Are Essential During Monitoring of Response to Mesenchymal Stromal Cell Therapy in Children with Gastrointestinal Acute Graft Versus Host Disease
PATIENT REPORTED OUTCOMES (PROS) IN PAEDIATRIC ONCOLOGY PRACTICE: PERCEIVED FEASIBILITY BY ONCOLOGISTS AND PARENTS
Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients
Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: Is it effective?
Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group
Mesenchymal stem cells suppress virus-specific T-cell responses in vitro
IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD
In Situ Detection of HY-Specific T Cells in Acute Graft-versus-Host Disease-Affected Male Skin after Sex-Mismatched Stem Cell Transplantation
Managing a dual roleuexperiences and coping strategies of parents donating haploidentical G-CSF mobilized peripheral blood stem cells to their children
Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma

Pages